The impact of primary diseases is substantial, demanding fresh therapeutic modalities. Cellular therapies represent a remarkably promising avenue, offering the potential to regenerate damaged hepatic tissue and improve clinical outcomes. Currently, research focuses on several methods, including the introduction of induced pluripotent stem cells dir